Mirna Therapeutics Inc

-

Stock Issuer and Owners

Home | Sign Up | Log In
Due Diligence for Asset Managers
You have viewed 10 of the 10 daily limit
Subscribe for $29/month to gain full access
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Mirna Therapeutics Inc
TickerSYBX
CIK #0001527599
CUSIP87166L100
SectorLife Sciences - Pharmaceutical Preparations
Address2150 Woodward St, Suite 100, Austin, TX 78744
Source [EDGAR]
Reg D Offering (Form D) Filed Raised Terms
Synlogic Inc 2019-06-18 80.0 M Exemption: 506(b) · Duration: One year or less · Revenue: Decline to Disclose
Mirna Therapeutics Inc 2015-05-01 41.8 M Exemption: 506(b) · Remaining: $3,210,473 · Duration: One year or less · Revenue: Decline to Disclose
CIK Filing 2011 - 2026
[0001527599] 10-K
[0001527599] 10-Q
[0001527599] 3
[0001527599] 4
[0001527599] 5
[0001527599] 8-K
[0001527599] D
[0001527599] SC 13D
[0001527599] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
Baselake Partners LP Synlogic Inc [2026-01-23] 0.0
Radoff Bradley Louis Synlogic Inc [2024-04-18] 5.4
Funicular Funds LP Synlogic Inc [2024-02-16] 36.0
Armistice Capital LLC Synlogic Inc [2024-02-14] 0.99
Kryzanowski John A Synlogic Inc [2023-01-20] 5.3
RA Capital Management LP Synlogic Inc [2021-10-01] 9.9
FMR LLC Synlogic Inc [2021-05-10] 0.0
Ginkgo Bioworks Inc Synlogic Inc [2019-06-21] 19.99
Aquilo Capital Management LLC Synlogic Inc [2019-02-14] 5.2
Wellington Management Group LLP Synlogic Inc [2018-05-10] 14.0
Hawkes Bay Master Investors Cayman LP Synlogic Inc [2018-04-16] 5.3
OrbiMed Advisors LLC Synlogic Inc [2017-09-07] 8.08
Flynn James E Synlogic Inc [2017-09-06] 5.22
Opaleye Management Inc Mirna Therapeutics Inc [2017-06-29] 11.0
Synlogic Inc Mirna Therapeutics Inc [2017-05-23] 32.9
FMR LLC Mirna Therapeutics Inc [2016-02-12] 0.0
Franklin Resources Inc Mirna Therapeutics Inc [2016-02-09] 6.9
Eastern Capital Ltd Mirna Therapeutics Inc [2015-10-15] 5.4
New Enterprise Associates 14 LP Mirna Therapeutics Inc [2015-10-14] 14.8
Pfizer Inc Mirna Therapeutics Inc [2015-10-14] 9.0
Sofinnova Venture Partners VIII LP Mirna Therapeutics Inc [2015-10-08] 11.0
Cancer Prevention & Research Institute of Texas Mirna Therapeutics Inc [2015-10-08] 11.9
Form 3/4/5 Filer 2011 - 2026
Synlogic Inc
Dooley Mary Beth
Flynn James P
Shea Richard P
Awad Antoine
Funicular Funds LP
Cable Car Capital LLC
Ma-Weaver Jacob
Hurter Patricia N
Barrett Peter
Brennan Aoife
Jensen Michael Vangsted
Kerins Patrick J
NEA Partners 14 LP
New Enterprise Associates 14 LP
Baskett Forest
NEA 14 GP Ltd
Florence Anthony A Jr
Sandell Scott D
Heffernan Michael Thomas
Mathers Edward T
Leschly Nick
Kelly-Croswell Lisa
Burgess Michael F
Beloff Gregg
OrbiMed Capital GP VI LLC
OrbiMed Advisors LLC
Khuong Chau Quang
Riese Richard J
Plevy Scott Eric
Ginkgo Bioworks Inc
Powell Michael
Shegog Todd
Miller Paul Francis
Gutierrez-Ramos Jose-Carlos
Gengos Andrew
Barris Peter J
Barrett M James
Viswanathan Ravi
Sonsini Peter W
Mott David M
Isaly Samuel D
Atlas Venture Fund IX LP
Irvin Jon
Nisen Perry
Winkler Matthew
Greenleaf Peter
Alleva Lawrence M
Siegall Clay B
O'Neill Vincent
Lammers Paul
Fuhrman Alan
DeYoung Casi
Cancer Prevention & Research Institute of Texas
Pfizer Inc
Weller Harry R
Sofinnova Management VIII LLC
Sofinnova Venture Partners VIII LP
Mehra Anand
Akkaraju Srinivas
Healy James
Kolluri Krishna Kittu
Jones Elaine V
Barbosa Miguel
Kim Sinil
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Dooley Mary Beth
Common Stock
2025-10-29 Sell 157 $1.81 284
Shea Richard P
Common Stock
2025-04-26 Grant 15,000 $0.00
Flynn James P
Common Stock
2025-04-26 Grant 15,000 $0.00
Dooley Mary Beth
Common Stock
2025-04-02 Sell 144 $1.20 173
Dooley Mary Beth
Common Stock
2025-02-03 Sell 2,107 $1.33 2,802
Dooley Mary Beth
Common Stock
2024-10-29 Sell 79 $1.40 111
Awad Antoine
Common Stock
2024-04-02 Sell 372 $1.73 644
Dooley Mary Beth
Common Stock
2024-04-02 Sell 188 $1.73 325
Flynn James P
Stock Option (right to buy) · derivative
2024-03-19 Grant 4,000 $0.00
Hurter Patricia N
Stock Option (right to buy) · derivative
2024-01-02 Grant 14,678 $0.00
Barrett Peter
Stock Option (right to buy) · derivative
2024-01-02 Grant 24,923 $0.00
Brennan Aoife
Stock Option (right to buy) · derivative
2023-11-10 Grant 9,999
Brennan Aoife
Stock Option (right to buy) · derivative
2023-11-10 Grant 12,352
Brennan Aoife
Stock Option (right to buy) · derivative
2023-11-10 Grant 18,999
Brennan Aoife
Stock Option (right to buy) · derivative
2023-11-10 Grant 28,943
Brennan Aoife
Stock Option (right to buy) · derivative
2023-11-10 Grant 42,999
Brennan Aoife
Stock Option (right to buy) · derivative
2023-11-10 Grant 8,666
Brennan Aoife
Stock Option (right to buy) · derivative
2023-11-10 Disposed to issuer 5,591
Brennan Aoife
Stock Option (right to buy) · derivative
2023-11-10 Disposed to issuer 3,733
Brennan Aoife
Stock Option (right to buy) · derivative
2023-11-10 Disposed to issuer 3,600
showing 20 of 200 most recent transactions
13F Ownership Over TimeHoldersShares Held
2026-03-31 2 23,783
2025-12-31 25 6,879,879
2025-09-30 23 6,655,294
2025-06-30 20 6,771,875
2025-03-31 19 6,780,519
2024-12-31 19 6,764,148
2024-09-30 18 6,826,011
2024-06-30 18 6,939,077
2024-03-31 18 6,928,904
2023-12-31 25 4,718,430
2023-09-30 29 2,675,567
2023-06-30 46 32,366,190
Form 13F Holdings
Firm Period DFND Voting Shares
Prev | Page 1 | Next
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com